Detection of human papillomavirus DNA, P53 and KI67 expression in penile carcinomas

International Journal of Immunopathology and Pharmacology

Volumn 19, Issue 1, 2006, Pages 209-215

  Gentile, V ^a   Vicini, P ^a   Giacomelli, L ^a   Cardillo, M R ^a   Pierangeli, A ^a   Degener, A M ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Virology Section   (Italy)

Author keywords

Human Papillomavirus (HPV); Ki67; p53; Penile cancer

Indexed keywords

KI 67 ANTIGEN; MONOCLONAL ANTIBODY; PROTEIN P53; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; DNA SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PAPILLOMA VIRUS; PENIS AMPUTATION; PENIS CARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; VIRUS DETECTION;

EID: 33646239820     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/205873920601900121     Document Type: Article

References (33)

1. Mobilio G. and V. Ficarra. 2001. Genital treatment of penile carcinoma. Curr. Opin. Urol. 11:299.
2. Kamat M.R., J.N. Kulkarni and H.B. Tongaonkar. 1993. Carcinoma of the penis: the Indian experience. J. Surg. Oncol. 52:50.
3. Fraley E.E., G. Zhang, R. Sazama and P.H. Lange. 1985. Cancer of the penis: prognosis and treatment plans. Cancer 55:1618.
4. Bezerra A.L., A. Lopes, G.H. Santiago, K.C. Ribeiro, M.R. Latorre and L.L. Villa. 2001. Human papillomavirus as prognostic factor in carcinoma of the penis: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. Cancer 91:2315.
5. Clifford G.M., J.S. Smith, M. Plummer, N. Munoz and S. Franceschi. 2003. Human Papillomavirus types in invasive cancer worldwide: a meta-analysis. Br. J. Cancer. 88:63.
6. Dianzani C., M. Bucci M, A. Pierangeli, S. Calvieri and A.M. Degener. 1998. Association of human Papillomavirus type 11 with carcinoma of the penis. Urology 51:1046.
7. Picconi M.A., A.M. Eijan, A.L. Distefano, S. Pueyo, L.V. Alonio, S. Gorostidi, A.R. Teyssie and A. Casabe. 2000. Human Papillomavirus (HPV) DNA in penile carcinomas in Argentina: analysis of primary tumors and lymph nodes. J. Med. Virol. 61:65.
8. Humbey O., S. Cairey-Remonnay, J.S. Guerrini, M.P. Algros, C. Mougin, H. Bittard and F. Aubin. 2003. Detection of the human Papillomavirus and analysis of the TP53 polymorphism of exon 4 at codon 72 in penile squamous carcinomas. Eur. J. Cancer 39:684.
9. Rogel A., M. Popliker, C.G. Webb and M. Oren. 1985. p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissue, embryos, and tumors. Mol. Cell. Biol. 5:2851.
10. Pharoah P.D., N.E. Day and C. Caldas. 1999. Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis. Br. J. Cancer 80:1968.
11. Goff B.A., H.G. Muntz, B.E. Greer, H.K. Tamimi and A.M. Gown. 1998. Oncogene expression: long-term compared with short-term survival in patients with advanced epithelial ovarian cancer. Obstet. Gynecol. 92:88.
12. Salvesen H.G., O.E. Iversen and L.A. Akslen. 1998. Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas. Clin. Cancer Res. 4:2779.
13. Hendricks J.B., E.J. Wilkinson, P. Kubilis, P. Drew, S.M. Blaydes and S. Munakata. 1994. Ki-67 expression in vulvar carcinoma. Int. J. Gynecol. Pathol. 13:205.
14. Marchetti M., R. Salmaso, S. Polonio, D. Perin, T. Salviato and A. Onnis. 1996. Ki 67 expression in vulvar carcinoma. Preliminary results. Eur. J. Gynaecol. Oncol. 17:361.
15. Modesitt S.C., P.A. Groben, L.A. Walton, W.C. Fowler and L. Van Le. 2000. Expression of Ki-67 in vulvar carcinoma and vulvar intraepithelial neoplasia III: correlation with clinical prognostic factors. Gynecol. Oncol. 76:51.
16. Lucia M.S. and G.J. Miller. 1992. Histopathology of malignant lesions of the penis. Urol. Clin. North Am. 19:227.
17. Sobin L.H. and C.H. Witteking. 2002. TNM classification of malignant tumours 6°Ed Wiley-Liss John Wiley & Sons, Inc., Hoboken, New Jersey, Publication p. 1.
18. Jackson S.M. 1966. The treatment of carcinoma of the penis. Br. J. Surg. 53:33.
19. Cardillo M.R., S. Monti, F. Di Silverio, V. Gentile, F. Sciarra and V. Toscano. 2003. Insulin-like growth factor (IGF)-I, IGF-II and IGF type I receptor (IGFR-I) expression in prostatic cancer. Anticancer Research 23:3825.
20. Alkushi A., P. Lim, A. Coldman, D. Huntsman, D. Miller and C.B. Gilks. 2004. Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off level. Int. J. Gynecol. Pathol. 23:129.
21. Martins A.C., S.M. Faria, A.J. Cologna, H.J. Suaid and S. Tucci. 2002. Immunoexpression of p53 protein and proliferating cell nuclear antigen in penile carcinoma. J. Urol. 167:89.
22. de Roda Husman A.M., J.M. Walboomers, A.J. van den Brule, C.J. Meijer and P.J. Snijders. 1995. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J. Gen. Urol. 76:1057.
23. Bernard H.U., S.V. Chan, M.M. Manos, C.K. Ong, L.L. Villa, H. Delius, C.L. Peyton, H.M. Bauer and C.M. Wheeler. 1994. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphism, nucleotide sequence, and phylogenetic algorithms. J. Infect. Dis. 170:1077.
24. Pisani S., M. Imperi, L. Seganti, F. Superti, A. Tinari, M. Bucci and A.M. Degener. 2004. Effect of HSV-2 infection on the expression of HPV 16 genes in CaSki cells. Int. J. Immunopathol. Pharmacol. 17:65.
25. Pisani S., D. Fioriti, M.P. Conte, F. Chiarini, L. Seganti and A.M. Degener. 2002. Involvement of herpes simplex type 2 in modulation of gene expression of human papillomavirus type 18. Int. J. Immunopathol. Pharmacol. 15:59.
26. Lopes A., A.L. Bezerra, C.A. Pinto, S.V. Serrano, C.A. de Mello and L.L. Villa. 2002. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. J. Urol. 168:81.
27. Rodriguez-Alonso A., S. Pita-Fernandez, J. Gonzales-Carrero and J.L. Noguera-March. 2002. p53 and ki67 expression as prognostic factors for cancer-related survival in stage T1 transitional cell bladder carcinoma. Eur. Urol. 41:182.
28. Bernardini S., G.L. Adessi, C. Billerey, E. Chezy, J.P. Carbillet and H. Bittard. 1999. Immunohistochemical detection of p53 protein overexpression versus gene sequencing in urinary bladder carcinomas. J. Urol. 162:1496.
29. Levi J.E., P. Rahal, A.S. Sarkis and L. Villa. 1998. Human Papillomavirus DNA and p53 status in penile carcinomas. Int. J. Cancer 76:779.
30. Zhang X.H., G.Q. Sun, Y. Yang and T.H. Zhang. 2001. Human papillomavirus and p53 protein immunoreactivity in condylomata acuminatum and squamous cell carcinoma of penis. Asian J. Androl. 3:75.
31. Lam K.Y., A.C. Chan, K.W. Chan, M.L. Leung and G. Srivastava. 1995. Expression of p53 and its relationship with human papillomavirus in penile carcinoma. Eur. J. Surg. Oncol. 21:613.
32. Suzuki H., N. Sato, T. Kodama, T. Okano, S. Isaka, H. Shirasawa, B. Simizu and J. Shimazaki. 1994. Detection of human papillomavirus DNA and state of p53 gene in Japanese penile cancer. Jpn. J. Clin. Oncol. 24:1.
33. Koyamatsu Y., M. Yokoyama, Y. Nakao, K. Fukuda, T. Saito, K. Matsukuma and T. Iwasaka. 2003. A comparative analysis of human Papillomavirus types 16 and expression of p53 and Ki-67 in cervical, vaginal, and vulvar carcinomas. Gynecol. Oncol. 90:547.